Evidence exists for the presence of a discrete tissue renin-angiotensin system (RAS) in mouse and rat pancreas that is thought largely to be associated with the vasculature. To investigate this in the human pancreas, and to establish whether the cellular sites of RAS components include the islets of Langerhans, we used immunocytochemistry to localise the expression of angiotensin II (AT1) receptors and (pro)renin, and non-isotopic in situ hybridisation to localise transcription of the (pro)renin gene. Identification of cell types in the islets of Langerhans was achieved using antibodies to glucagon and insulin.
Introduction
The renin-angiotensin system (RAS) has important roles in the vascular system, and its principal hormonal product, angiotensin II (Ang II), is involved in regulation of blood pressure and aldosterone secretion, as well as sodium and potassium homeostasis (Peach 1977) . In addition, localised tissue RASs have been described that either potentiate these systemic functions or have entirely separate activities, in the adrenal, uterus (Capponi et al. 1980 , Wang et al. 1992 , Whitebread et al. 1989 , gonads , heart (Phillips et al. 1993) , kidney (Okura et al. 1992 ), brain and pituitary (Mendelssohn et al. 1984 , Trolliet et al. 1992 , and in our own studies, the use of a specific monoclonal antibody to the Ang II AT1 receptor has shown that it can be localised by immunocytochemistry in many different tissues (Barker et al. 1993b , Vinson et al. 1995a . In the pancreas, recent studies have suggested that the RAS is important in the regulation of islet blood flow (and thus, indirectly, insulin release) in the rat and mouse (Carlsson et al. 1998) , and of anion secretion in the mouse exocrine pancreas (Leung et al. 1998) . Additionally, angiotensin converting enzyme inhibition modulates mitosis in pancreatic cancer cells, and in human mammary ductal carcinoma cells (Redpy et al. 1995 , Small et al. 1994 . Since Ang II and the tissue RASs appear to play both autocrine and paracrine roles in other tissues (Small et al. 1994 , Vinson et al. 1995a , it was thought important to assess this possibility in the human pancreas.
This paper describes the use of immunohistochemical and in situ hybridisation techniques to localise AT1 receptors and sites for (pro)renin production in the human pancreas.
Materials and Methods

Tissue collection
The sections of human pancreas were generously provided by Drs C Brown and C Nichols, Department of Morbid Anatomy, Royal Hospitals Trust, London, E1 1BB. These were post mortem specimens usually taken, after cold storage, within hours of decease. Tissues were in good condition, and showed no signs of autolysis.
Immunocytochemistry
Primary antibodies used were: for the AT1 receptor, mouse monoclonal antibody 6313/G2 (Barker et al. 1993b) , for renin and for (pro)renin, monoclonal antibody 2D12, a generous gift from Professor Pierre Corvol (Collège de France).
Monoclonal antibodies against glucagon and insulin were obtained from the Sigma Chemical Co., (Poole, Dorset, UK).
Sections (8 µm) were dehydrated, incubated in 3% hydrogen peroxide in methanol (v/v) for 15 min, boiled for 16 min in 10 mmol/l citrate buffer, and washed in Tris buffered saline (TBS, pH 7·6, 50 mmol Tris/l, 150 mmol NaCl/l, 2 mmol MgCl 2 /l). To block non-specific binding, sections were first incubated for 20 min with normal rabbit serum (Sigma, 1:5 dilution) in TBS before incubation (60 min for 6313/G2, 30 min for 2D12) with primary antibody (for 6313/G2: neat hybridoma supernatant, RPMI 1640 culture medium (ICN-Flow Ltd, High Wycombe, Bucks., UK), for 2D12: diluted 1000-fold in TBS). Sections were then washed twice and left to soak in TBS (5 min). Sections were then exposed to biotinylated rabbit anti mouse IgG complex (Dako Ltd, High Wycombe, Bucks, UK), diluted 1:400 in TBS (30 min), washed in TBS then incubated for 30 min with avidin-biotin complex (Dako), and washed again in TBS. Visualisation of receptor was achieved through the diaminobenzidine hydrochloride (DAB)-hydrogen peroxide chromogen substrate reaction (Sigma) using 0·6 mg DAB and 1·6 mg hydrogen peroxide per ml in TBS (0·05 mol/l for 10 min). Slides were washed in water (10 min), counterstained in Gills haematoxylin (2 min), re-washed in water (5 min), differentiated briefly in acid alcohol (10 ml of 1% HCl in 990 ml of 70% industrial methylated spirit (IMS), BDH Lab. supplies, Poole, Dorset, UK), dehydrated in IMS, cleared with xylene twice and mounted in Depex mounting medium (BDH Ltd, Poole, Dorset, UK).
As a further control for AT1 staining, sections were also treated with antibody previously saturated with the peptide antigen (Barker et al. 1993b ). In addition, further sections were stained with another mouse monoclonal, IZAb, as primary antibody (Laird et al. 1988 ).
In situ hybridisation
Oligonucleotide probes, 45 bases comprising antisense (base pairs 187-142) and sense sequences (base pairs 142-187) were derived from the translated exon 2 of the human renin gene. Probes were enzymatically labelled with a digoxigenin (DIG)-labelled nucleotide tail with incorporation of several DIG-dUTP molecules at their 3 -end using terminal transferase (Boehringer Mannheim, Lewes, Sussex, UK).
The hybridised DIG-labelled probes were detected with high affinity alkaline phosphatase-conjugated sheep anti-DIG antibody (1:200 dilution in modified TBS). Pancreas tissue sections were post-fixed in 0·4% (w/v) paraformaldehyde in PBS (pH 7·4, 20 mmol NaH 2 PO 4 /l, 80 mmol NaHPO 4 /l and 100 mmol NaCl/l) for 15 min. The sections were then incubated with 0·25% acetic anhydride (v/v) in 0·1 mol triethanolamine/l and 0·9% (w/v) NaCl solution and incubated for 10 min, followed by washing in diethyl pyrocarbonate (DEPC) water. Sections were covered with hybridisation buffer (pH 7·5, 10 mmol Tris/l), 50% (v/v) formamide, 4 SSC (1 SSC contains 150 mmol sodium chloride/l and 15 mmol trisodium citrate/l), 1 Denhardt's solution, 500 µg salmon sperm DNA/ml (Sigma), 10% (v/v) dextran sulphate containing DIG 3 -end labelled oligonucleotide probe to human renin, and incubated at 37 overnight. The unhybridized probe was washed away with serial washing in 4 SSC, 2 SSC and 1 SSC (35 min at 37 ) and for further 15 min in modified TBS (pH 7·6, 50 mmol Tris/l), 150 mmol NaCl/l, 2 mmol MgCl 2 /l and 0·1% (w/v) BSA with added 0·1% (v/v) Triton X-100 at room temperature. Sections were incubated with blocking reagent (Boehringer Mannheim) 1% (w/v) for 10 min, followed by incubation with alkaline phosphatase-conjugated sheep anti-DIG antibody (1:200 dilution) for 3 h. Excess antibody was removed by washing with TBS (pH 9·5, 100 mmol Tris/l and 100 mmol NaCl/l). The antibody was visualised using 5-bromo-4-chloro-3-indolyl phosphate (BCIP 165 µg/ ml) and nitro blue tetrazolium salt (NBT 330 µg/ml) for 2-20 h at room temperature. Levamisole (0·1 mmol/l) was added to the substrate solution to reduce endogenous alkaline phosphatase activity. Finally, sections were washed in TE (pH 7·4, 10 mmol Tris/l, 1 mmol EDTA/l, Sigma) buffer for 30 min and mounted with Apathys mounting medium (Sigma).
Results
Immunocytochemistry
Positive staining for the AT1 receptor (antibody: 6313/ G2) was found in cells of the islets of Langerhans (Fig. 1A) . These were distributed similarly to cells staining for insulin, but not for glucagon (not shown). Sections treated similarly, but using antibody presaturated with peptide antigen (or in the absence of primary antibody) showed no immunostaining (Fig. 1B) . Additionally, sections using another primary antibody, IZAb, or from which primary antibody was omitted altogether, showed no staining (not illustrated). Further immunocytochemistry for (pro)renin (using antibody 2D12) also demonstrated positive staining in islets, with a distribution similar to that of the AT1 receptor (Fig. 1C) , and also in endothelial cells of blood vessels within the gland (not shown). Controls from which the primary antibody was omitted showed no staining (Fig. 1D) .
In situ hybridisation
Using the antisense hybridisation probe, messenger RNA coding for prorenin was seen in reticular fibres within the islets of Langerhans (Fig. 1E ) and in fibroblasts surrounding the blood vessels (Fig. 1G) . The sense probe controls showed no staining ( Fig. 1F & H) .
Discussion
Interest in the relationship between the systemic RAS and endocrine pancreas function has largely been concerned with the role of Ang II in the the hypertension of diabetes, its complications such as nephropathy, and retinopathy, and their possible control by drugs regulating its action (Hsueh & Anderson 1993 , Vandyk et al. 1994 , Tait & Tait 1997 , Goa 1997 , Allen 1997 , Anderson 1997 , Kim et al. 1997 , Chaturvedi et al. 1998 . In addition, studies with experimental animals as well as patients have shown that the systemic RAS may be perturbed in diabetes, though the situation is complex, and opposing effects, for example on Ang II receptor function have been reported in different tissues (Sechi et al. 1994 , Cheng et al. 1994 , Fliser et al. 1997 , Brown et al. 1997 , Nakata et al. 1998 . ACE inhibition may also affect the action of insulin, though this might be attributable to increased bradykinin (Carvalho et al. 1997) .
The actions of anti-Ang II drugs, may not, however, always be at the level of the systemic RAS, and the local tissue RASs may also be involved, for example in the kidney (Anderson et al. 1997) , or eye (Wagner et al. 1996) . It is in this context that the possibility that the pancreas itself may contain a localised tissue RAS acquires a special interest. Clear evidence of this possibility was described in the canine pancreas, in which the presence of angiotensinogen mRNA and protein, Ang II, and both AT1 and AT2 receptors was demonstrated (Chappell et al. 1991 (Chappell et al. , 1992 . Autoradiography showed that receptors were present both in acinar and in islet cells (Chappell et al. 1992 (Chappell et al. , 1995 , though the AT2 subtype predominated.
Although a similar distribution of Ang II binding sites in both endocrine and acinar cells of the rat pancreas has been described in studies using ligand binding methods, other reports, in which polyclonal antibodies to peptides derived from the AT1 and AT2 receptor subtypes were used, suggest that the major site for Ang II binding in rat or mouse pancreas lies within the endothelial cells of the blood vessels, and the epithelia of the ductal system, in which Ang II was subsequently shown to stimulate anion secretion (Leung et al. 1997 , Chan et al. 1997 . However, only weak reactivity was seen in acinar cells, and none was reported for the endocrine pancreas (Leung et al. 1997) . A similar distribution was also reported for Ang II itself (Leung, Chan & Wong 1998) . That Ang II may have a significant effect on pancreatic blood flow is clear, and indeed, in rats it appears to delay the response to glucose, perhaps mainly as a result of its vasocontrictive action (Carlsson, Berne & Jansson 1998) . The question of the presence of Ang II receptors in the endocrine pancreas, and its relationship to possible sites of endogenous Ang II production, however, requires resolution for species other than the dog, and has a clear relevance to our understanding of endocrine pancreas function in health and in disease.
It is important to emphasise that the monoclonal antibody against the AT1 receptor used in the present study is highly specific. Evidence includes the following: (1) Demonstration of immunoreactivity in Western blots from COS-7 cells transfected with cDNA coding for AT1, but not in untransfected cells (Barker et al. 1993a) .
(2) Demonstration of single immunoreactive bands corresponding in molecular weight to the AT1 receptor in western blots of membrane fractions from adrenals and other target tissues. Though some of these sites (e.g. sperm, fallopian tube, breast) had not previously been shown to possess AT1 receptors, the findings were substantiated either by ligand binding studies, or the demonstration of AT1 specific responses to Ang II (Vinson et al. 1995a ,b, Saridogan et al. 1996a ,b, Inwang et al. 1997 . (3) Pre-saturation of antibody with the antigen eliminates immunostaining of immunopositive sections (HarrisonBernard et al. 1997) . (4) In rat adrenal cells, incubation with antibody specifically inhibits receptor internalisation and Ang II-stimulated protein kinase C activation , Kapas et al. 1994 .
Within the limits of the material available to us, therefore, we believe that the results shown in Fig. 1A give good prima facie evidence that the human endocrine pancreas does indeed contain AT1 receptors and, from their distribution, these appear to be primarily located on beta cells. Acinar cells did not contain AT1 receptors, although in agreement with others they are certainly present in the endothelial cells of the blood vessels.
In other epithelial, or epithelioid, tissues in which we have similarly shown the presence of AT1 receptors, other data, obtained by immunocytochemistry or in situ hybridisation have also shown that specifically localised RASs may exist that deliver Ang II directly to its sites of action in a paracrine manner. This is certainly true, for example, in the rat adrenal, in which we and others have demonstrated the regulation of (pro)renin expression in a manner that suggests its key role in tissue modelling and the secretory response to systemic stimulation (Mulrow et al. 1996 . In the breast too, ductal epithelia are surrounded by fibroblasts and myoepithelial tissue that transcribe (pro)renin mRNA (Tahmasebi et al. 1998) . This has parallels in the present study in which cells lying within the islets contain (pro)renin mRNA (Fig. 1E) . However, use of a monoclonal antibody against (pro)renin shows that the protein occurs mostly in the beta cells themselves (Fig. 1C) , raising the possibility that (pro)renin, synthesised in the reticular fibres within the islets, may be taken up by the pancreatic endocrine cells. Uptake of renin in target cells has been been suggested in other contexts (Sealey 1995 , Sealey et al. 1996 . Figure 1 Immunocytochemistry shows the distribution of AT1 receptors (brown stain) in beta cells of the islets of Langerhans in human pancreas. It is absent from reticular fibres (A). Control sections, using antibody presaturated with peptide antigen, showed no staining (B). The distribution of renin (brown stain) is similarly confined to beta cells of the islets (C). Control sections again showed no immunoreactivity (D). In situ hybridisation shows that prorenin mRNA (dark stain) was transcribed in the reticular fibres of islets (E) and the fibroblasts and connective tissue surrounding blood vessels (G). The negative controls, using sense probe, showed no staining (F & H). Magnification 166 throughout.
Ang II, it is becoming clear, has widely distributed functions in many different epithelia, or epithelial-derived cells, associated with a local RAS that presumably responds in a manner quite separate from that of the systemic RAS, and in accordance with specific tissue functions. The endocrine pancreas is no exception to this, and the results presented here clearly link the RAS with beta cell function, under normal conditions, and plausibly, in disease.
